CDT Equity Inc.
About CDT Equity Inc.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$39.2M
- Total assets
- $5.7M
- Market cap
- $3.6M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $3.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 25, 2023
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review CDT Equity Inc..